BH
Benjamin Hohl (CHIEF FINANCIAL OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $296K of ELVN (10,000 sh × $29.58, as filed), executed Mar 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Oct 19
Filed Oct 21
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$232K6,018 sh × $38.48
Exec Oct 19
Filed Oct 21 · 5:53 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $288K
5,729 sh across 2 lots
Exec Sep 17
Filed Sep 21 · 5:23 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $270K
4,630 sh × $58.35
Exec Aug 17
Filed Aug 19 · 4:17 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $275K
5,202 sh across 2 lots
Exec Jul 17
Filed Jul 21 · 5:24 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $149K
3,401 sh × $43.86
Exec Jun 17
Filed Jun 22 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $296K
10,000 sh × $29.58
Exec Mar 6
Filed Mar 10 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $105K
4,250 sh × $24.78
Exec Nov 27 2024
Filed Dec 2 2024 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $160K
5,600 sh × $28.49
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET